
A professional-grade long-acting calcium channel blocker used to treat high blood pressure and coronary artery disease (angina).
In the competitive landscape of cardiovascular medicine, ingredient quality defines the clinical outcome. Zyntex Amlodipine besylate is selected for its ability to enhance vessel relaxation and therapeutic efficacy without compromising patient safety. Therefore, we utilize an advanced synthesis process to maintain a stable dihydropyridine structure. Consequently, this versatile ingredient delivers reliable performance across a wide range of cardiac conditions, ensuring effective management of hypertension and coronary artery disease in human medical treatments.
Zyntex supplies Amlodipine besylate in a highly stable white crystalline powder form, optimized for easy integration into complex tablet compression and capsule filling processes. Our stringent quality control measures ensure high purity and minimal organic impurity content to preserve its pharmacological integrity. Furthermore, this product features a consistent chemical profile. Since it acts by inhibiting the transmembrane influx of calcium ions into vascular smooth muscle, you can incorporate it into various products like oral tablets, combined antihypertensive pills, or laboratory reagents without affecting the intended therapeutic experience.
From specialized laboratory research to large-scale industrial manufacturing, this versatile ingredient is a staple for modern formulation. Its consistent chemical profile ensures it does not interfere with the desired characteristics of the end product. As a result, Zyntex provides a dependable foundation for innovation in the chronic disease and hypertensive care markets. Finally, our commitment to safety and international standards helps your brand achieve regulatory compliance and global market trust effortlessly.
This professional-grade cardiovascular agent is widely utilized in the following sectors:
It acts as a primary active component to lower blood pressure and reduce the risk of fatal cardiovascular events.
This is an essential ingredient for tablets designed for long-lasting action and once-daily dosing convenience.
Used as a primary treatment in clinical settings for patients suffering from vasospastic or chronic stable angina.
A high-grade reference standard for studying calcium channel antagonism and vascular resistance research.
| Parameter | Specification Standard |
|---|---|
| Product Name | Amlodipine besylate |
| Grade | Pharmaceutical Grade (USP/EP) |
| Assay | 97.0% – 102.0% (Anhydrous Basis) |
| Category | Calcium Channel Blockers & Cardiovascular API |
| CAS Number | 111470-99-6 |
🔬 Scientific Data: For detailed handling, solubility, and safety data, consult: PubChem Entry: Amlodipine besylate (External Link)